How Commonly Are Brain Tumors Seen in Spasmus Nutans?
Discussion
Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus).
Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
How cost-effective is intraoperative MRI for gliomas?
Using a simulated clinical decision analysis model, researchers from the University...Read more on AuntMinnie.comRelated Reading:
Workflow optimization cuts MRI turnaround time
Imaging analytics platform optimizes MRI operations
MRA is cost-effective for kidney disease-related aneurysms
Study reveals steep cost of delaying stroke treatment
MRI for knee pain adds cost with negligible benefit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 2, 2019 Category: Radiology Source Type: news
Clinical trial finds therapy to be well-tolerated in patients with aggressive brain tumour
A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients. The trial used a treatment combination of ADI-PEG20, pemetrexed and cisplatin, which showed encouraging efficacy in patients with recurrent high-grade gliomas (HGGs), a disease for which little progress has been made over the last few decades. (Source: World Pharma News)
Source: World Pharma News - March 29, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
SIR: Virtual reality beats fluoroscopy for catheter placement
Virtual reality may be a safer, more time-efficient alternative to conventional...Read more on AuntMinnie.comRelated Reading:
VR, AR elevate radiologists' value in future of medicine
Virtual reality may help plan, guide glioma resection
3D printing gives pediatric heart surgery a boost
Virtual reality, 3D printing resolve obscure lung cancer
Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2019 Category: Radiology Source Type: news
New drug combination shows promise for common pediatric brain tumor
(Johns Hopkins Medicine) A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news
Augmented reality cultivates early radiology education
An interactive educational course that uses augmented reality technology to...Read more on AuntMinnie.comRelated Reading:
VR, AR elevate radiologists' value in future of medicine
AR aids image-guided spinal procedures on live patients
AR improves operative view for robotic thyroid surgery
AR, 3D printing make headway in patient education
Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news
VR, AR elevate radiologists' value in future of medicine
How can virtual reality (VR) and augmented reality (AR) help radiologists advance...Read more on AuntMinnie.comRelated Reading:
AR aids image-guided spinal procedures on live patients
AR improves operative view for robotic thyroid surgery
Virtual reality may help plan, guide glioma resection
VR, AR may revamp cardiovascular imaging
Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2019 Category: Radiology Source Type: news
Gadolinium breast MRI screening OK for healthy women
VIENNA - Healthy women at high risk for developing breast cancer should have...Read more on AuntMinnie.comRelated Reading:
Video from ECR 2019: Alexander Radbruch on gadolinium debate
Gadolinium in gliomas, adjacent tissue raises questions
German study may offer new way to detect gadolinium
Patients report long-term gadolinium presence in urine
Gadolinium accumulation might be more widespread than thought (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2019 Category: Radiology Source Type: news
Promising strategy to fight the most deadly brain tumor in children
(Ann& Robert H. Lurie Children's Hospital of Chicago) A study published in Nature Communications found that an inhibitor of an enzyme called ACVR1 slows tumor growth and increases survival in an animal model of diffuse intrinsic pontine glioma (DIPG) -- the most deadly brain tumor in children. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2019 Category: Cancer & Oncology Source Type: news
Super-enhancers: novel target for pancreatic ductal adenocarcinoma
(Rapamycin Press) Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news
Blocking DNA repair restores sensitivity of brain tumors to treatment in mice
Researchers found that blocking DNA repair made gliomas, a type of deadly brain tumor, more responsive to radiation therapy in mice. The study suggests possible treatment strategies. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 26, 2019 Category: Consumer Health News Source Type: news
Study unveils a blueprint for treating a deadly brain tumor
(NIH/National Institute of Neurological Disorders and Stroke) In a study of mice and human brain tumors researchers at the University of the Michigan, Ann Arbor, searched for new treatments by exploring the reasons why some patients with gliomas live remarkably longer than others. The results suggested that certain patients' tumor cells are less aggressive and much better at repairing DNA than others but are difficult to kill with radiation. The researchers then showed that combining radiation therapy with cancer drugs designed to block DNA repair may be an effective treatment strategy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 19, 2019 Category: Cancer & Oncology Source Type: news
Gadolinium in gliomas, adjacent tissue raises questions
Researchers have discovered the presence of gadolinium from MRI contrast in...Read more on AuntMinnie.comRelated Reading:
German study may offer new way to detect gadolinium
Gadolinium accumulation might be more widespread than thought
AI may help in fight against gadolinium deposition
Is gadolinium deposition disease really a disease? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2019 Category: Radiology Source Type: news
Burn-induced neuroepithelial changes as a delayed cause of mortality in major burns: a case report and literature review - Obeid DA, Alhujayri AK, Aldekhayel S.
BACKGROUND: Mortality in major burns is caused mainly by multisystem organ failure. Brain lesions in burn patients are rare and predominantly traumatic in nature. Here, we present an unusual case of burn-induced glioma causing rapid neurological deteriorat... (Source: SafetyLit)
Source: SafetyLit - February 1, 2019 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
Apatinib Case Study Uncovers Potential Mesothelioma Treatment
Doctors in China may have uncovered an effective second- or third-line treatment option for patients with malignant pleural mesothelioma.
Dr. RongQin Meng, an oncologist at 363 Hospital in Cheng Du, said the investigational drug Apatinib (rivoceranib) could become part of a much-needed advance in mesothelioma treatment.
After first- and second-line chemotherapy combinations had failed to slow tumor growth in a 58-year-old woman, Apatinib provided a five-month progression-free survival.
“I was surprised at the result,” Meng told The Mesothelioma Center at Asbestos.com. “After taking the drug, the quality of life was g...
Source: Asbestos and Mesothelioma News - January 31, 2019 Category: Environmental Health Authors: Daniel King Source Type: news
